Universe Pharmaceuticals (UPC) Notes Payables: 2020-2024
- Universe Pharmaceuticals' Notes Payables rose 6.83% to $5.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.9 million, marking a year-over-year increase of 6.83%. This contributed to the annual value of $5.9 million for FY2024, which is 6.83% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Notes Payables stood at $5.9 million for Q3 2024, which was up 32.15% from $4.4 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Notes Payables ranged from a high of $2,646.0 billion in Q3 2020 and a low of $3.9 million during Q3 2022.
- Moreover, its 3-year median value for Notes Payables was $4.4 million (2022), whereas its average is $4.7 million.
- Its Notes Payables has fluctuated over the past 5 years, first plummeted by 100.00% in 2021, then spiked by 39.28% in 2023.
- Over the past 5 years, Universe Pharmaceuticals' Notes Payables (Quarterly) stood at $2,646.0 billion in 2020, then crashed by 100.00% to $4.3 million in 2021, then declined by 9.19% to $3.9 million in 2022, then spiked by 39.28% to $5.5 million in 2023, then grew by 6.83% to $5.9 million in 2024.
- Its Notes Payables was $5.9 million in Q3 2024, compared to $4.4 million in Q1 2024 and $5.5 million in Q3 2023.
